Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
May 20, 2009

moksha8 Broadens Partnership with Roche to Commercialize More Products in Mexico

  • moksha8 expanded its strategic partnership with Roche to commercialize an additional portfolio of products in Mexico, currently generating sales of $140 million.

    moksha8 will commercialize products in three therapeutic areas—CNS disease, anti-infectives, and inflammation. The product portfolio consists of well-known brands including Rivotril®, Rocephin®, and Bactrim®.

    “moksha8 has established a broad footprint in Latin America, with leading products that are cornerstones of medical care,” said Simba Gill, CEO of moksha8. “We look forward to continuing our strong relationship with Roche and driving value from this important portfolio of products.”



Be sure to take the GEN Poll

Cancer vs. Zika: What Worries You Most?

While Zika continues to garner a lot of news coverage, a Mayo Clinic survey reveals that Americans believe the country’s most significant healthcare challenge is cancer. Compared to other diseases, does the possibility of developing cancer worry you the most?

More »